LivaNova

Youtube Subscribe

Open: 53.99 Close: 53.64 Change: -0.35

You're losing the opportunity of using an AI to get informed about LivaNova Company Inc Stock.

This document will help you to evaluate LivaNova without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about LivaNova are: LivaNova, share, result, quarter, company, LivaNovas, PLC, and the …

Concept Map

Semantic Network

Stock Summary

LivaNova PLC designs, develops, manufactures, and sells therapeutic solutions. The Cardiopulmonary segment develops, produces, and markets cardiopul pulmonary products. Neuromodulation segment designs, markets VNS Therapy.

Today's Summary

Panagora Asset Management Inc. has significantly increased its stake in LivaNova PLC. Institutional investors command an impressive 97.64% control over LivaNovas stock. Angiostomy cannula market predicted double-digit growth rate.

Today's News

LivaNova recently announced its earnings results for the quarter ending on July 26th. The company sold 3,133 shares during the first quarter, resulting in a 61.9% decrease in its holdings. LivaNovas is projected to achieve an EPS of 2.39 for the current fiscal year. LivaNova PLC is a global medical technology company. It engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. Panagora Asset Management Inc. has significantly increased its stake in LivaNova PLC, according to the companys recent filing with the Securities and Exchange Commission, boosted its position in LIVN shares by an impressive 474.9%. The firm now owns 224,945 shares, an increase of 185,816 shares from the previous period. Institutional investors command an impressive 97.64% control over LivaNovas stock. The interest in LivaNova has also extended to Guggenheim Capital LLC and Y Intercept Hong Kong Ltd. The Street upgraded its rating on Liva Angiostomy cannula market predicted double-digit growth rate by 2030. Angiastomy Cannula Market Predicted Double-Digit Growth Rate by 2030. Head of Global Investigations will work to establish and ensure full implementation of compliance goals.

Stock Profile

"LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom."

Keywords

Are looking for the most relevant information about LivaNova? Investor spend a lot of time searching for information to make investment decisions in LivaNova. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about LivaNova are: LivaNova, share, result, quarter, company, LivaNovas, PLC, and the most common words in the summary are: livanova, job, medical, device, neuromodulation, stock, share, . One of the sentences in the summary was: Angiostomy cannula market predicted double-digit growth rate.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #livanova #job #medical #device #neuromodulation #stock #share.

Read more →

Youtube Subscribe

---